You Position: Home > Paper
顺铂对TRAIL蛋白抑制子宫颈癌细胞生长的调节作用
( views:179, downloads:100 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Issue:
- 8
- DOI:
- 10.3321/j.issn:0529-567X.2008.08.020
- Key Word:
- No keyword available
Abstract： @@ 宫颈癌是世界范围内威胁妇女生命健康的主要妇科恶性肿瘤,对于晚期和复发患者,化疗是主要的治疗方法,但其严重的副反应及肿瘤耐药是导致患者死亡的主要原因.因此,寻求高效、低毒的化疗药物用于宫颈癌的治疗,是急需探寻的课题.TRAIL蛋白是新近发现的肿瘤坏死因子(TNF)家族的成员,因其能够选择性地诱导多种肿瘤细胞凋亡而不影响正常细胞的生长,有望成为新型的化疗药物.本研究观察TRAIL蛋白以及顺铂调节TRAIL蛋白对宫颈癌细胞株HeLa和Caski细胞生长的影响,探讨TRAIL蛋白用于宫颈癌治疗的可行性,并为临床应用提供新的思路和科学依据.
- [1]Gibson SB,Oyer R,Spalding AC,etc.Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL.[J].2000,20(1).
- [2]Larisa L, Belyanskaya,Thomas M, Marti,Sally, Hopkins-Donaldson,etc.Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin.[J].2007,6.
- [3]S R, Wiley,K, Schooley,P J, Smolak,etc.Identification and characterization of a new member of the TNF family that induces apoptosis.[J].1995,3(6).